Astrana Health Inc Q2 EPS USD 0.4
ASTH•Second-quarter results
Astrana Health Inc reported second-quarter revenue of USD 972.5 million versus the IBES estimate of USD 985.7 million.
- Q2 adjusted EBITDA: USD 68.9 million vs. IBES estimate USD 67.7 million
- Q2 adjusted EPS: USD 0.8 vs. IBES estimate USD 0.34




